Genome-wide study of hypomethylated and induced genes in patients with liver cancer unravels novel anticancer targets

Clinical Cancer Research

Volumn 20, Issue 12, 2014, Pages 3118-3132

  Stefanska, Barbara ^a,d   Cheishvili, David ^a   Suderman, Matthew ^a   Arakelian, Ani ^a   Huang, Jian ^e   Hallett, Michael ^b   Han, Ze Guang ^e   Al Mahtab, Mamun ^f   Akbar, Sheikh Mohammad Fazle ^h   Khan, Wasif Ali ^g   Raqib, Rubhana ^g   Tanvir, Imrana ⁱ   Khan, Haseeb Ahmed ⁱ   Rabbani, Shafaat A ^a   Szyf, Moshe ^a,c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d PURDUE UNIVERSITY   (United States)

^e CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^f BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

^g INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^h Shinagawa ku   (Japan)

ⁱ FATIMA MEMORIAL HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; WNT PROTEIN; CARRIER PROTEIN; CYSTEINE PROTEINASE; EXOSC4 PROTEIN, HUMAN; EXOSOME MULTIENZYME RIBONUCLEASE COMPLEX; METHYLTRANSFERASE; MRNA (GUANINE(N7))-METHYLTRANSFERASE; NENF PROTEIN, HUMAN; NERVE PROTEIN; RASAL2 PROTEIN, HUMAN; RNA BINDING PROTEIN; SENP6 PROTEIN, HUMAN; SIGNAL PEPTIDE; TUMOR MARKER; WBSCR22 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER CELL LINE; CANCER GROWTH; CANCER TISSUE; CELL INVASION; CELL VIABILITY; CLINICAL ARTICLE; DEPLETION; DNA METHYLATION; ENZYME PHOSPHORYLATION; EXOSC4 GENE; GENE MAPPING; GENETIC SCREENING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NENF GENE; NOD SCID MOUSE; NONHUMAN; PRIORITY JOURNAL; PYROSEQUENCING; RASAL2 GENE; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNMT GENE; SENP6 GENE; SIGNAL TRANSDUCTION; TUMOR GENE; TUMOR INVASION; TUMOR XENOGRAFT; WBSCR22 GENE; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETICS; LIVER TUMOR; NONOBESE DIABETIC MOUSE; PROMOTER REGION; SCID MOUSE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CYSTEINE ENDOPEPTIDASES; DNA METHYLATION; EXOSOME MULTIENZYME RIBONUCLEASE COMPLEX; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MALE; METHYLTRANSFERASES; MICE; MICE, INBRED NOD; MICE, SCID; NERVE TISSUE PROTEINS; PROMOTER REGIONS, GENETIC; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84902689867     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-0283     Document Type: Article

References (43)

1. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 2001;10:687-92. (Pubitemid 32331576)
2. Stefanska B, Huang J, Bhattacharyya B, Suderman M, Hallett M, Han ZG, et al. Definition of the landscape of promoter DNA hypomethylation in liver cancer. Cancer Res 2011;71:5891-903.
3. Szyf M. DNA methylation and demethylation as targets for anticancer therapy. Biochemistry (Mosc) 2005;70:533-49. (Pubitemid 40920798)
4. Szyf M. Towards a pharmacology of DNA methylation. Trends Pharmacol Sci 2001;22:350-4. (Pubitemid 32592473)
5. Szyf M. Epigenetics, DNA methylation, and chromatin modifying drugs. Annu Rev Pharmacol Toxicol 2009;49:243-63.
6. Yang X, Lay F, Han H, Jones PA. Targeting DNA methylation for epigenetic therapy. Trends Pharmacol Sci 2010;31:536-46.
7. Andersen JB, Factor VM, Marquardt JU, Raggi C, Lee YH, Seo D, et al. An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer. Sci Transl Med 2010;2:54ra77.
8. Dante R, Dante-Paire J, Rigal D, Roizes G. Methylation patterns of long interspersed repeated DNA and alphoid repetitive DNA from human cell lines and tumors. Anticancer Res 1992;12:559-63.
9. Mayol G, Martin-Subero JI, Rios J, Queiros A, Kulis M, Sunol M, et al. DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis. PLoS ONE 2012;7:e48401.
10. Pakneshan P, Szyf M, Rabbani SA. Hypomethylation of urokinase (uPA) promoter in breast and prostate cancer: prognostic and therapeutic implications. Curr Cancer Drug Targets 2005;5:471-88. (Pubitemid 41502560)
11. Rauch TA, Zhong X, Wu X, Wang M, Kernstine KH, Wang Z, et al. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci U S A 2008;105:252-7.
12. Sato N, Fukushima N, Matsubayashi H, Goggins M. Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene 2004;23:1531-8. (Pubitemid 38406515)
13. Yue Y, Lypowy J, Hedhli N, Abdellatif M. Ras GTPase-activating protein binds to Akt and is required for its activation. J Biol Chem 2004;279:12883-9. (Pubitemid 38445863)
14. Weeks A, Okolowsky N, Golbourn B, Ivanchuk S, Smith C, Rutka JT. ECT2 and RASAL2 mediate mesenchymal-amoeboid transition in human astrocytoma cells. Am J Pathol 2012;181:662-74.
15. Kimura I, Yoshioka M, Konishi M, Miyake A, Itoh N. Neudesin, a novel secreted protein with a unique primary structure and neurotrophic activity. J Neurosci Res 2005;79:287-94. (Pubitemid 40278342)
16. Han KH, Lee SH, Ha SA, Kim HK, Lee C, Kim DH, et al. The functional and structural characterization of a novel oncogene GIG47 involved in the breast tumorigenesis. BMC Cancer 2012;12:274.
17. Doll A, Grzeschik KH. Characterization of two novel genes, WBSCR20 and WBSCR22, deleted in Williams-Beuren syndrome. Cytogenet Cell Genet 2001;95:20-7. (Pubitemid 34461821)
18. Nakazawa Y, Arai H, Fujita N. The novel metastasis promoter Merm1/Wbscr22 enhances tumor cell survival in the vasculature by suppressing Zac1/p53-dependent apoptosis. Cancer Res 2011;71:1146-55.
19. Best JL, Ganiatsas S, Agarwal S, Changou A, Salomoni P, Shirihai O, et al. SUMO-1 protease-1 regulates gene transcription through PML. Mol Cell 2002;10:843-55. (Pubitemid 35335639)
20. Bawa-Khalfe T, Yeh ET. SUMO losing balance: SUMO proteases disrupt SUMO homeostasis to facilitate cancer development and progression. Genes Cancer 2010;1:748-52.
21. Li Y, Song MG, Kiledjian M. Transcript-specific decapping and regulated stability by the human Dcp2 decapping protein. Mol Cell Biol 2008;28:939-48. (Pubitemid 351160050)
22. Ensinger MJ, Moss B. Modification of the 5′ terminus of mRNA by an RNA (guanine-7-)-methyltransferase from HeLa cells. J Biol Chem 1976;251:5283-91.
23. Cowling VH. Enhanced mRNA cap methylation increases cyclin D1 expression and promotes cell transformation. Oncogene 2010;29:930-6.
24. de Larco JE, Todaro GJ. Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci U S A 1978;75:4001-5. (Pubitemid 8399860)
25. Slack A, Cervoni N, Pinard M, Szyf M. DNA methyltransferase is a downstream effector of cellular transformation triggered by simian virus 40 large T antigen. J Biol Chem 1999;274:10105-12.
26. Colella S, Shen L, Baggerly KA, Issa JP, Krahe R. Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques 2003;35:146-50. (Pubitemid 36828724)
27. Tost J, Gut IG. DNA methylation analysis by pyrosequencing. Nat Protoc 2007;2:2265-75. (Pubitemid 351575045)
28. Frodin M, Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 1999;151:65-77.
29. Yang SH, Sharrocks AD, Whitmarsh AJ. MAP kinase signalling cascades and transcriptional regulation. Gene 2013;513:1-13.
30. Wiggin GR, Soloaga A, Foster JM, Murray-Tait V, Cohen P, Arthur JS. MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol Cell Biol 2002;22:2871-81. (Pubitemid 34263007)
31. Soloaga A, Thomson S, Wiggin GR, Rampersaud N, Dyson MH, Hazzalin CA, et al. MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. EMBO J 2003;22:2788-97. (Pubitemid 36712374)
32. Razin A, Riggs AD. DNA methylation and gene function. Science 1980;210:604-10.
33. Boilly B, Vercoutter-Edouart AS, Hondermarck H, Nurcombe V, Le Bourhis X. FGF signals for cell proliferation and migration through different pathways. Cytokine Growth Factor Rev 2000;11:295-302.
34. Dreesen O, Brivanlou AH. Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev 2007;3:7-17. (Pubitemid 47472808)
35. Issa JP, Vertino PM, Wu J, Sazawal S, Celano P, Nelkin BD, et al. Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst 1993;85:1235-40. (Pubitemid 23223530)
36. Wu J, Issa JP, Herman J, Bassett DE Jr., Nelkin BD, Baylin SB. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc Natl Acad Sci U S A 1993;90:8891-5. (Pubitemid 23306416)
37. MacLeod AR, Szyf M. Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis. J Biol Chem 1995;270:8037-43.
38. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 1995;81:197-205.
39. Ramchandani S, MacLeod AR, Pinard M, von Hofe E, Szyf M. Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc Natl Acad Sci U S A 1997;94:684-9. (Pubitemid 27053694)
40. Pakneshan P, Szyf M, Farias-Eisner R, Rabbani SA. Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis. J Biol Chem 2004;279:31735-44. (Pubitemid 39037845)
41. Shukeir N, Pakneshan P, Chen G, Szyf M, Rabbani SA. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo. Cancer Res 2006;66:9202-10. (Pubitemid 44521141)
42. Campbell PM, Bovenzi V, Szyf M. Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivo. Carcinogenesis 2004;25:499-507. (Pubitemid 38499940)
43. Sansom OJ, Berger J, Bishop SM, Hendrich B, Bird A, Clarke AR. Deficiency of Mbd2 suppresses intestinal tumorigenesis. Nat Genet 2003;34:145-7. (Pubitemid 36666922)